MHRA update on COVID-19

Dear Colleague,

This email updates you on details of recently published MHRA guidance on the coronavirus (COVID-19) pandemic aimed at supporting healthcare partners.

Confirmation of guidance to vaccination centres on managing allergic reactions following COVID-19 vaccination with the Pfizer/BioNTech vaccine

We have issued updated guidance to COVID-19 vaccination centres about the management of anaphylaxis, following two reports of anaphylaxis and one report of a possible allergic reaction following immunisation.

Please see our website for updated information for healthcare professionals and the public.

We also request that reports for any suspected adverse drug reactions or side effects from medicines and adverse incidents involving medical equipment relating to COVID-19 treatment be reported through the COVID-19 Yellow Card reporting site.

Update from MHRA’s CEO explaining how we approved the first COVID-19 vaccine

MHRA Chief Executive Dr June Raine explains the process behind the Agency's approval of the Pfizer/BioNTech vaccine.

Please see our website for further information.

Medical devices given exceptional use authorisations during the COVID-19 pandemic

We have updated the list of medical devices given exceptional use authorisations and the list of devices no longer covered.

Guidance for industry

We continue to update our guidance page for industry on GOV.UK as our response to COVID-19 evolves.

Subscribing to updates on GOV.UK

You can sign up for email updates about the MHRA’s work – you will then receive an email every time the MHRA publishes a new page or makes a significant edit to an existing page.

Contacting the MHRA

Most of our workforce is working from home, although National Institute for Biological Standards and Control (NIBSC) is continuing essential laboratory activities on site. If you need to get in touch with the MHRA during this period, please email info@mhra.gov.uk or phone 0203 080 6000.

For more information please visit mhra.gov.uk.

We welcome your feedback on what other information you would find useful – please email engagement@mhra.gov.uk.

Kind regards,

Patient, Public and Stakeholder Engagement team
Communications division

Medicines and Healthcare products Regulatory Agency
10 South Colonnade, Canary Wharf, London E14 4PU
Telephone: 0203 080 6000
Email: engagement@mhra.gov.uk
gov.uk/mhra

Read our guidance on coronavirus (COVID-19)

If you would like to share this with a friend or colleague, hit the Forward button or send them this link to view the email in a browser.

Unsubscribe or change your email address at any time on your subscriber preferences page.

If you have questions or problems with the subscription service, please visit subscriberhelp.govdelivery.com.

All other enquiries can be directed to email.support@mhra.gov.uk.

This is an automatically generated email. Please do not reply directly to this notification.
This service is provided to you at no charge by the Medicines and Healthcare products Regulatory Agency.